Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
ecopipam HCl ~2mg/kg/day
DRUG
2 trials
Sponsors
Emalex Biosciences Inc.
Conditions
Drug-Interactions
Tourette Disorder
Tourettes Disorder
Phase 1
Drug-Drug Interaction Study to Evaluate the Effects of Ecopipam on the Pharmacokinetics of Multiple Substrates
Terminated
NCT04764851
Emalex Biosciences Inc.
Drug-Interactions
Start: 2021-02-18
End: 2021-05-07
Updated: 2021-05-24
Unknown Phase
Expanded Access Program for Treatment With Ecopipam for Tourette's Disorder
NCT07093541
Emalex Biosciences Inc.
Tourette Disorder, Tourettes Disorder
Updated: 2026-05-18